BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30647991)

  • 1. Acute Cerebellar Ataxia Associated with Modest Elevation of Anti-GAD Antibodies in a Young Patient.
    Gomez J; Jin D
    Tremor Other Hyperkinet Mov (N Y); 2018; 8():620. PubMed ID: 30647991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebellar ataxia and autoantibodies restricted to glutamic acid decarboxylase 67 (GAD67).
    Guasp M; Solà-Valls N; Martínez-Hernández E; Gil MP; González C; Brieva L; Saiz A; Dalmau J; Graus F; Ariño H
    J Neuroimmunol; 2016 Nov; 300():15-17. PubMed ID: 27806870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of oral corticosteroids therapy in anti-glutamic acid decarboxylase antibodies cerebellar ataxia.
    di Biase L; Assenza G; Iorio R; Melgari JM; Salomone G; Marano M; Muda AO; Di Lazzaro V
    Parkinsonism Relat Disord; 2016 Sep; 30():78-80. PubMed ID: 27236207
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
    Honnorat J; Saiz A; Giometto B; Vincent A; Brieva L; de Andres C; Maestre J; Fabien N; Vighetto A; Casamitjana R; Thivolet C; Tavolato B; Antoine J; Trouillas P; Graus F
    Arch Neurol; 2001 Feb; 58(2):225-30. PubMed ID: 11176960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of patients with cerebellar ataxia associated with anti-GAD antibodies.
    Aguiar TS; Fragoso A; Albuquerque CR; Teixeira PF; Souza MV; Zajdenverg L; Alves-Leon SV; Rodacki M; Lima MA
    Arq Neuropsiquiatr; 2017 Mar; 75(3):142-146. PubMed ID: 28355320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
    Birand B; Cabre P; Bonnan M; Olindo S; Smadja D
    Rev Med Interne; 2006 Aug; 27(8):616-9. PubMed ID: 16797794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Treatment Resistance and Complications in a Patient with Stiff Person Syndrome and Cerebellar Ataxia.
    Jones LA; Baber W; Wardle M; Robertson NP; Morris HR; Church A; Llewelyn JG; Peall KJ
    Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31646058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-titer anti-GAD-antibody-positive cerebellar ataxia.
    Nanri K; Niwa H; Mitoma H; Takei A; Ikeda J; Harada T; Okita M; Takeguchi M; Taguchi T; Mizusawa H
    Cerebellum; 2013 Apr; 12(2):171-5. PubMed ID: 22923147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Titer of Circulating Antiglutamic Acid Decarboxylase Antibodies in a Patient with Cerebellar Ataxia and Type 1 Diabetes.
    Kataria R; Fernandes S; Lebastchi J; Bravo CA; Sena KN
    Conn Med; 2017 Mar; 81(3):161-164. PubMed ID: 29772159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABA-A receptor impairment in cerebellar ataxia with anti-glutamic acid decarboxylase antibodies.
    Hosoi Y; Suzuki-Sakao M; Terada T; Konishi T; Ouchi Y; Miyajima H; Kono S
    J Neurol; 2013 Dec; 260(12):3086-92. PubMed ID: 24091766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies.
    Vale TC; Pedroso JL; Alquéres RA; Dutra LA; Barsottini OG
    J Neurol Sci; 2015 Dec; 359(1-2):21-3. PubMed ID: 26671081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochondrin Antibody Serum Positivity in Three Cases of Autoimmune Cerebellar Ataxia.
    Weihua Z; Haitao R; Fang F; Xunzhe Y; Jing W; Hongzhi G
    Cerebellum; 2019 Dec; 18(6):1137-1142. PubMed ID: 31179511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
    Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
    Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Homer-3 antibody associated cerebellar ataxia: A rare case report and literature review.
    Xu X; Ren H; Li L; Wang J; Fechner K; Guan H
    J Neuroimmunol; 2019 May; 330():155-158. PubMed ID: 30904736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-GAD Antibody, Seizures, Cerebellar Ataxias and Vitiligo: A Diagnostic Challenge.
    Flores-Cantu H; Camara-Lemarroy CR; Calderon-Hernandez HJ; Zapata-Rivera MA; Villareal-Perez JZ; Villareal-Velazquez HJ
    Cerebellum; 2015 Jun; 14(3):375-7. PubMed ID: 25575726
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies.
    Vianello M; Tavolato B; Armani M; Giometto B
    Cerebellum; 2003; 2(1):77-9. PubMed ID: 12882238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoantibodies associated with autoimmune-mediated cerebellar ataxia].
    Mitoma H; Nanri K
    Brain Nerve; 2013 Apr; 65(4):355-64. PubMed ID: 23568983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lesson of the month 2: Autoimmune sequelae of anti-GAD antibodies - thinking outside the box.
    Ward RJ; Varughese GI; Jose B; Abraham RJ
    Clin Med (Lond); 2017 Oct; 17(5):473-474. PubMed ID: 28974603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.